{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:29:49Z","timestamp":1775561389588,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1053\/j.ajkd.2007.12.038","type":"journal-article","created":{"date-parts":[[2008,4,4]],"date-time":"2008-04-04T11:57:10Z","timestamp":1207310230000},"page":"724-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial"],"prefix":"10.1053","volume":"51","clinical-trial-number":[{"clinical-trial-number":"nct00319761","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Cheuk-Chun","family":"Szeto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Ming","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie Ching-Ha","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwok-Yi","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Bon","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip Kam-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2007.12.038_bib1","first-page":"709","article-title":"The commonest glomerulonephritis in the world: IgA nephropathy","volume":"245","author":"D'Amico","year":"1987","journal-title":"Q J Med"},{"key":"10.1053\/j.ajkd.2007.12.038_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ndt\/17.1.64","article-title":"Prognostic indicators of IgA nephropathy in the Chinese\u2014Clinical and pathological perspectives","volume":"17","author":"Li","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2007.12.038_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0272-6386(97)90456-X","article-title":"Histologic subclassification of IgA nephropathy: A clinico-pathologic study of 244 cases","volume":"29","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.12.038_bib4","first-page":"265","article-title":"ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: A multicentre, randomized, placebo-controlled study","volume":"9","author":"Maschio","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2007.12.038_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0272-6386(99)70416-6","article-title":"Additive anti-proteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy","volume":"33","author":"Russo","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.12.038_bib6","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1681\/ASN.V9122308","article-title":"The antiproteinuria effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin","volume":"9","author":"Perico","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.12.038_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.ajkd.2006.01.017","article-title":"Hong Kong study using valsartan in IgA nephropathy (HKVIN): A double-blind, randomized, placebo-controlled study","volume":"47","author":"Li","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.12.038_bib8","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2006040347","article-title":"IgACE: A placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria","volume":"18","author":"Coppo","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.12.038_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0272-6386(00)70054-0","article-title":"Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury","volume":"35","author":"Ruggenenti","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.12.038_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.V124846","article-title":"Treating IgA nephropathy","volume":"12","author":"Dillon","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.12.038_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","article-title":"Corticosteroids in IgA nephropathy: A randomized controlled trial","volume":"353","author":"Pozzi","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2007.12.038_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1046\/j.1523-1755.1998.00951.x","article-title":"Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats","volume":"53","author":"Schwarz","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.12.038_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0272-6386(00)70191-0","article-title":"Outcome of IgA nephropathy in adults graded by chronic histological lesions","volume":"35","author":"To","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.12.038_bib14","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","article-title":"Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease","volume":"17","author":"Ma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2007.12.038_bib15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1152\/physrev.1998.78.4.1193","article-title":"Current understanding of the molecular actions of vitamin D","volume":"78","author":"Jones","year":"1998","journal-title":"Physiol Rev"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2007.12.038_bib16","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1053\/ajkd.1998.v32.pm9808141","article-title":"Vitamin D analogues","volume":"32","author":"Brown","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2007.12.038_bib17","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/endo-124-5-2645","article-title":"A synthetic analogue of vitamin D3, 22-oxa-1\u03b1,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice","volume":"124","author":"Abe","year":"1989","journal-title":"Endocrinology"},{"key":"10.1053\/j.ajkd.2007.12.038_bib18","doi-asserted-by":"crossref","first-page":"20874","DOI":"10.1074\/jbc.274.30.20874","article-title":"A vitamin D analog regulates mesangial cell smooth muscle phenotypes in a transforming growth factor-\u03b2 type II receptor-mediated manner","volume":"274","author":"Abe","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1053\/j.ajkd.2007.12.038_bib19","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0002-9440(10)64129-6","article-title":"A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis","volume":"158","author":"Makibayashi","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1053\/j.ajkd.2007.12.038_bib20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1523-1755.2005.00562.x","article-title":"1,25-Dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression","volume":"68","author":"Li","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.12.038_bib21","doi-asserted-by":"crossref","first-page":"F526","DOI":"10.1152\/ajprenal.00316.2003","article-title":"1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat","volume":"286","author":"Kuhlmann","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1053\/j.ajkd.2007.12.038_bib22","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1093\/ndt\/17.12.2132","article-title":"22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats","volume":"17","author":"Hirata","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2007.12.038_bib23","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1111\/j.1523-1755.2005.00755.x","article-title":"Antiproteinuric effect of oral paricalcitol in chronic kidney disease","volume":"68","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2007.12.038_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2007.12.038_bib25","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1681\/ASN.2006091028","article-title":"Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats","volume":"18","author":"Mizobuchi","year":"2007","journal-title":"J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608001558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608001558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:49:00Z","timestamp":1759456140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608001558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0272638608001558"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.12.038","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1108431.564482","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2007.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.03.013","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}